Last update:

Ophthalmology news

Semaglutide and other GLP-1 drugs not linked to risk of degenerative eye disease in adults with type 2 diabetes

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight loss. Some research ...

Researchers investigate potential connections between menopausal hormone therapy and ocular health

Faculty members at the University of Colorado Anschutz School of Medicine are working together across academic departments to learn more about how menopausal hormone therapy, sometimes referred to as hormone replacement therapy, ...

Patient-specific 3D-printed contact lenses in just 20 minutes

A breakthrough combination of new silicone materials and advanced 3D printing technology developed by University of Waterloo researchers could transform how contact lenses are manufactured. The study, "Patient-specific hard ...

Lab-grown retinal cells show promise for new eye therapies

Biomedical engineers at Duke University have used induced pluripotent stem cells (iPSCs) to grow specialized blood vessel cells critical to retinal health for the first time. When injected into mouse models of retinal disease, ...

Faded letters, early warnings: A new clue for aging eyes

Struggling to read more than six lines on an eye chart with fading letters may serve as a visual "yellow light" for older adults—raising red flags that routine exams sometimes fail to detect. A new University of Michigan ...

A global push to recognize the threat of toxoplasmosis

One-third of the world's population is infected with the Toxoplasma parasite, which can cause ocular toxoplasmosis, an eye infection that can damage the retina and result in permanent vision loss. Although often seen as an ...

Project expands access to care for children with amblyopia

A group of pediatric eye disease researchers has launched an open-access tool designed to help manage pediatric cases of amblyopia, a condition in which the brain fails to properly develop normal vision in one or both eyes ...

Low-dose eye drops can manage adult myopia for 24 hours

Groundbreaking research from the University of Houston shows that a single low-dose atropine eye drop can produce daylong effects in managing myopia, or nearsightedness, which affects roughly one-third of U.S. adults. Professor ...

Seeing keratoconus earlier with light polarization and AI

Keratoconus is a progressive eye disease that weakens and thins the cornea, the clear front surface of the eye. In its early, subclinical stage, the cornea can still appear normal on routine exams. Yet this is when accurate ...

'MitoCatch' delivers healthy mitochondria to diseased cells

Scientists led by Botond Roska at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) have developed MitoCatch, a system that enables targeted delivery of healthy mitochondria to specific cell types affected ...